China Resources Pharmaceutical (03320): China Resources Pharmaceutical Commercial was approved to issue 10 billion yuan of debt financing instruments and 10 billion yuan of corporate bonds

Zhitongcaijing · 2d ago

Zhitong Finance App News, China Resources Pharmaceutical (03320) announced that China Resources Pharmaceutical Commercial Group Co., Ltd. (China Resources Pharmaceutical Commercial), a non-wholly-owned subsidiary of the company, has received a notice of acceptance from the Bank of China Intermarket Dealers Association for China Resources Pharmaceutical Commercial's intention to issue debt financing instruments in the People's Republic of China (China Market Cooperation Note [2026] PDFI177). The debt financing instrument registration notice is valid for two years from the date of the debt financing instrument registration notice. China Resources Pharmaceutical Commercial can issue debt financing instruments totaling RMB 10 billion in installments during this period, including ultra-short-term financing notes, short-term financing notes, medium-term notes and perpetual notes.

China Resources Pharmaceutical Commercial has received a registration approval notice from the China Securities Regulatory Commission regarding China Resources Pharmaceutical Commercial's intention to issue corporate bonds to eligible investors in China (Securities Regulatory License [2026] No. 3164). The corporate bond registration notice is valid for 24 months from the date the corporate bond registration notice is issued. During the period of validity, China Resources Pharmaceutical Commercial can issue corporate bonds totaling RMB 10 billion in installments.